biote Corp. (BTMD) CFO receives 107,169 employee stock options at $1.43

Rhea-AI Filing Summary

biote Corp. Chief Financial Officer Robert Charles Peterson received a grant of 107,169 employee stock options for Class A Common Stock. The options have an exercise price of $1.43 per share and expire on March 31, 2036.

After this award, Peterson holds 107,169 derivative securities. According to the vesting schedule, 25% of the options vest on April 1, 2027, with the remaining options vesting in 36 substantially equal monthly installments thereafter, contingent on his continued service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Peterson Robert Charles

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy)	107,169	$0.00	--

Holdings After Transaction: Employee Stock Option (Right to Buy) — 107,169 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 107,169 options Exercise price: $1.43 per share Post-grant derivative holdings: 107,169 derivative securities +3 more

6 metrics

Options granted 107,169 options Employee Stock Option grant to CFO on April 1, 2026

Exercise price $1.43 per share Conversion or exercise price for Class A Common Stock

Post-grant derivative holdings 107,169 derivative securities Total options held following this transaction

Option expiration date March 31, 2036 Expiration of employee stock option grant

Initial vesting tranche 25% of options Vests on April 1, 2027, subject to continuous service

Remaining vesting period 36 monthly installments Vesting schedule after April 1, 2027

Key Terms

Employee Stock Option (Right to Buy), Class A Common Stock, vesting, derivative securities

4 terms

Employee Stock Option (Right to Buy) financial

"security_title: "Employee Stock Option (Right to Buy)""

Class A Common Stock financial

"underlying_security_title: "Class A Common Stock""

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

vesting financial

"25% of the shares subject to the option shall vest on April 1, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

derivative securities financial

"total_shares_following_transaction: "107169.0000" (derivative transaction)"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Peterson Robert Charles

(Last) (First) (Middle)

C/O BIOTE CORP.

1875 W. WALNUT HILL LN #100

(Street)

IRVING TEXAS 75038

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
biote Corp. [ BTMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$1.43	04/01/2026		A		107,169		(1)	03/31/2036	Class A Common Stock	107,169	$0.00	107,169	D

Explanation of Responses:

1. 25% of the shares subject to the option shall vest on April 1, 2027, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

	/s/ Kendal McNeely, as Attorney-in-Fact for Peterson, Robert Charles	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did biote Corp. (BTMD) disclose about Robert Peterson’s latest equity award?

biote Corp. reported that CFO Robert Charles Peterson received 107,169 employee stock options for Class A Common Stock. These options are a compensation grant, not an open‑market purchase, and give him the right to buy shares at a preset exercise price in the future.

How many stock options did BTMD’s CFO receive and at what exercise price?

Robert Charles Peterson was granted 107,169 employee stock options with an exercise price of $1.43 per share. This means he can later buy up to 107,169 shares of Class A Common Stock at $1.43, subject to the vesting schedule and expiration date.

When do the newly granted BTMD stock options to the CFO vest?

For the new grant, 25% of Peterson’s options vest on April 1, 2027. The remaining 75% vest in 36 substantially equal monthly installments afterward, as long as he continues serving the company through each vesting date, aligning the award with long‑term employment.

What is the expiration date of Robert Peterson’s new BTMD stock options?

The granted employee stock options expire on March 31, 2036. If unexercised by that date, the options lapse and can no longer be used to purchase Class A Common Stock, making the award time‑limited despite its long‑term horizon.

How many derivative securities does BTMD’s CFO hold after this option grant?

Following the grant, Peterson holds 107,169 derivative securities related to this option award. This reflects the total options from this transaction recorded in his direct ownership, as reported in the Form 4 filing data.